Aterian (NASDAQ:ATER – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.18) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.40, Zacks reports. Aterian had a negative return on equity of 56.01% and a negative net margin of 17.05%. The firm had revenue of $24.61 million during the quarter, compared to the consensus estimate of $23.48 million. Aterian updated its FY 2025 guidance to EPS.
Aterian Stock Performance
NASDAQ ATER opened at $2.70 on Thursday. The business has a fifty day moving average price of $2.20 and a 200 day moving average price of $2.56. Aterian has a one year low of $1.86 and a one year high of $3.96. The company has a market cap of $23.64 million, a P/E ratio of -0.99 and a beta of 2.03.
Aterian declared that its board has approved a stock buyback plan on Tuesday, March 18th that permits the company to repurchase $3.00 million in shares. This repurchase authorization permits the company to purchase up to 16.2% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.
Aterian Company Profile
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
See Also
- Five stocks we like better than Aterian
- How to Invest in the FAANG Stocks
- Intel Stock Rallies on Leadership Change—Time to Buy or Wait?
- The How And Why of Investing in Oil Stocks
- 3 Semiconductor Stocks Flying Under the Radar—But Not for Long
- Consumer Discretionary Stocks Explained
- Despite Downturns, Analysts Say These 4 Financial Stocks Are Buys
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.